What caused the intraday drop in ALEUP.PA stock on 24 Mar 2026?

The intraday fall to EUR 0.0198 (-17.50%) reflected heavy selling on EURONEXT, elevated relative volume (2.47x), and ongoing negative fundamentals including EPS -88.61. Thin market cap amplified the move.

What is Meyka AI's short-term forecast for ALEUP.PA stock?

Meyka AI's forecast model projects monthly EUR 0.11 and quarterly EUR 0.37. Versus the current EUR 0.0198 this implies large percentage moves. Forecasts are model-based and not guarantees.

Is ALEUP.PA stock a buy after this drop?

Given negative cash flows, deeply negative book value, and liquidity risk, Meyka AI assigns a HOLD grade (66.25/100). Investors should wait for clear operational improvement or balance sheet repair before buying.

Where can I find live quotes and news for ALEUP.PA stock?

For live quotes and recent headlines see the Europlasma page on Investing.com and the company site. Example: [Investing.com Europlasma page](https://de.investing.com/equities/europlasma-sa).

EU Stocks

Intraday: Europlasma (ALEUP.PA) down 17.50% on 24 Mar 2026: watch EUR 0.0198 support

ByDanny Kontos March 24, 2026March 24, 2026

ALEUP.PA stock fell 17.50% intraday to EUR 0.0198 on 24 Mar 2026, led by heavy volume of 2,276,813 shares on EURONEXT. The drop places Europlasma S.A. well below its 50-day average of EUR 0.0606 and highlights acute liquidity and valuation stress. Traders should note the tiny market cap of EUR 57,048 and deeply negative EPS of -88.61, which shape risk for short-term holders.